SPI — Spire Healthcare Income Statement
0.000.00%
Last trade - 00:00
- £984.07m
- £2.19bn
- £1.36bn
- 38
- 47
- 73
- 52
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 981 | 557 | 1,048 | 1,195 | 1,359 |
Cost of Revenue | |||||
Gross Profit | 451 | 93.1 | 433 | 535 | 624 |
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 887 | 703 | 961 | 1,103 | 1,233 |
Operating Profit | 93.5 | -146 | 86.9 | 92.3 | 126 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 9.6 | -231 | -1.9 | 3.9 | 34.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.2 | -234 | -8.9 | 8.2 | 27.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 7.2 | -234 | -9.7 | 8.6 | 27.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 7.2 | -234 | -9.7 | 8.6 | 27.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.024 | -0.459 | -0.091 | 0.042 | 0.076 |
Dividends per Share |